Pharma Reviews: RBI eyes offshore transfer of IP assets by pharma firms

For years, several Indian pharma companies have been moving their prized possessions of intellectual property (IP) assets to offshore subsidiaries in ...
Read more: RBI eyes offshore transfer of IP assets by pharma firms